Hypoxia and HIF-1α in chondrogenesis

作者: Ernestina Schipani

DOI: 10.1016/J.SEMCDB.2005.03.003

关键词:

摘要: In endochondral bone development chondrocytes undergo well-ordered and controlled phases of proliferation, hypertrophic differentiation, mineralization the surrounding matrix, death, blood vessel invasion, finally replacement cartilage with bone. The chondrocytic growth plate is a unique mesenchymal tissue, as it avascular but requires i.e. angiogenic switch, in order to be replaced by We have recently provided evidence that hypoxic during fetal development. Adaptation hypoxia critical event numerous pathological settings, such tumor progression survival tissues which flow has been suddenly interrupted. One hallmarks response activation transcription factor HIF-1alpha. von Hippel Lindau suppressor protein VHL component ubiquitin ligase promoting proteolysis By using genetic approach, we demonstrated essential role hypoxia/VHL/HIF-1alpha pathway Hypoxia-dependent up regulation HIF-1alpha transcriptional activity for chondrocyte, shapes inhibiting chondrocyte increasing matrix accumulation probably modulating cell size. findings overall highlight usefulness studying model address issues adaptation normal hypoxia, cells, switch. They also demonstrate crucial differentiation.

参考文章(54)
Hans-Peter Gerber, Thiennu H Vu, Anne M Ryan, Joe Kowalski, Zena Werb, Napoleone Ferrara, None, VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation Nature Medicine. ,vol. 5, pp. 623- 628 ,(1999) , 10.1038/9467
T. Cramer, E. Schipani, R.S. Johnson, B. Swoboda, D. Pfander, Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1α dependent Osteoarthritis and Cartilage. ,vol. 12, pp. 433- 439 ,(2004) , 10.1016/J.JOCA.2004.02.003
Darwin J. Prockop, Adult stem cells gradually come of age. Nature Biotechnology. ,vol. 20, pp. 791- 792 ,(2002) , 10.1038/NBT0802-791
Fiona A Mack, W.Kimryn Rathmell, Andrew M Arsham, James Gnarra, Brian Keith, M.Celeste Simon, Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell. ,vol. 3, pp. 75- 88 ,(2003) , 10.1016/S1535-6108(02)00240-4
William G Kaelin, Eamonn R Maher, The VHL tumour-suppressor gene paradigm Trends in Genetics. ,vol. 14, pp. 423- 426 ,(1998) , 10.1016/S0168-9525(98)01558-3
Ernestina Schipani, Sylvain Provot, PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development Birth Defects Research Part C-embryo Today-reviews. ,vol. 69, pp. 352- 362 ,(2003) , 10.1002/BDRC.10028
Michael Ohh, William G Kaelin, William Kaelin, The von Hippel–Lindau tumour suppressor protein: new perspectives Molecular Medicine Today. ,vol. 5, pp. 257- 263 ,(1999) , 10.1016/S1357-4310(99)01481-1
Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter, None, The biology of VEGF and its receptors. Nature Medicine. ,vol. 9, pp. 669- 676 ,(2003) , 10.1038/NM0603-669
Nicholas C Denko, Lucrezia A Fontana, Karen M Hudson, Patrick D Sutphin, Soumya Raychaudhuri, Russ Altman, Amato J Giaccia, Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. ,vol. 22, pp. 5907- 5914 ,(2003) , 10.1038/SJ.ONC.1206703
Adrian Erlebacher, Ellen H Filvaroff, Stephen E Gitelman, Rik Derynck, Toward a molecular understanding of skeletal development Cell. ,vol. 80, pp. 371- 378 ,(1995) , 10.1016/0092-8674(95)90487-5